Research and Markets: Global Dental Pain Pipeline Review Report, H1 2013 Edition

Fri Jun 7, 2013 12:27pm EDT

* Reuters is not responsible for the content in this press release.

Research and Markets: Global Dental Pain Pipeline Review Report, H1 2013 Edition

Research and Markets ( has announced the addition of the "Dental Pain - Pipeline Review, H1 2013" report to their offering.

'Dental Pain - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Dental Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Pain.


- A snapshot of the global therapeutic scenario for Dental Pain.

- A review of the Dental Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Dental Pain pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Involved in Dental Pain Therapeutics Development

  • Novartis AG
  • Pfizer Inc.
  • IBSA Institut Biochimique SA
  • NeuroDiscovery Ltd
  • Array BioPharma Inc.

Drug Profiles

  • ARRY-797
  • NSL-101
  • diclofenac sodium
  • SAF-312-A
  • PF-05089771
  • 29B-S
  • 18c-S
  • 34B-S

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases